文献速递系统性红斑狼疮

牛磺酸代谢通过促进浆细胞样树突状细胞功能加重狼疮进展

Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells.
PubMed 文献 · Arthritis Rheumatol · 2020-10-25

该研究通过质谱代谢组学发现SLE患者血清牛磺酸水平高于健康对照和类风湿关节炎患者,且与疾病活动度和I型干扰素特征基因表达正相关。牛磺酸通过NCF1依赖方式降低pDC活性氧水平、促进IRF7磷酸化,增强I型干扰素产生,并在小鼠中加重肾炎。靶向抑制牛磺酸或限制牛磺酸饮食具有治疗潜力。

要点

  • SLE患者血清牛磺酸升高,与疾病活动度和I型干扰素特征基因表达正相关。
  • 牛磺酸通过NCF1依赖方式降低pDC活性氧、促进IRF7磷酸化,增强I型干扰素产生。
  • 牛磺酸补充在小鼠中加重狼疮肾炎,靶向抑制牛磺酸或限制饮食有治疗潜力。

核心结论

  • 牛磺酸代谢通过增强pDC介导的I型干扰素产生参与SLE发病,靶向抑制牛磺酸或限制牛磺酸饮食具有治疗潜力。

研究设计与样本

  • 对SLE患者和健康对照血清进行质谱代谢组学分析,并在人及小鼠pDC中探索SLE相关代谢物对I型干扰素产生的影响。
  • 采用野生型和Ncf1-/-小鼠的pDC通过流式细胞术检测活性氧水平,通过RNA测序和免疫印迹研究机制。
  • 在B6.Cg-Sle1NZM2410/Aeg Yaa/DcrJ小鼠中系统分析SLE相关代谢物的体内效应。

主要发现

  • SLE患者血清牛磺酸高于健康对照(P < 0.001)和类风湿关节炎患者(P < 0.001),牛磺酸含量与疾病活动度和干扰素特征基因表达正相关。
  • 添加牛磺酸以中性粒细胞胞浆因子1依赖方式降低pDC活性氧水平,促进干扰素调节因子7磷酸化,增强I型干扰素产生。
  • 补充牛磺酸促进I型干扰素诱导基因表达、激活淋巴细胞、增加自身抗体和蛋白尿,导致更严重的肾炎。

临床怎么用

  • SLE患者血清牛磺酸水平可能作为疾病活动度和I型干扰素通路的潜在生物标志物。
  • 靶向抑制牛磺酸或实施限制牛磺酸饮食可能成为SLE的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type I interferons (IFNs) are critical in the development of systemic lupus erythematosus (SLE). Metabolic abnormalities cause dysregulation of multiple immune cells, but the metabolic regulation of type I IFN production is not well clarified in SLE. We undertook this study to define amino acid metabolism features in SLE and to explore the function of disease-relevant metabolites in the control of plasmacytoid dendritic cell (pDC)-mediated type I IFN production and the progression of SLE. METHODS: Metabolomic profiling of the serum from SLE patients and healthy controls was performed by mass spectrometry. The effects of SLE-related metabolites on type I IFN production were explored in human and mouse pDCs. The reactive oxygen species (ROS) levels of pDCs from wild-type and Ncf1-/- mice were measured by flow cytometry. Mechanisms were investigated by RNA sequencing and immunoblotting. In vivo effects of SLE-relevant metabolites were systemically analyzed in B6.Cg-Sle1NZM2410/Aeg Yaa/DcrJ mice. RESULTS: Taurine was higher in the serum from SLE patients compared to healthy controls (P < 0.001) and rheumatoid arthritis patients (P < 0.001). Taurine content was positively correlated with disease activity and the expression of IFN signature genes. The addition of taurine facilitated IFN regulatory factor 7 phosphorylation and enhanced type I IFN production by reducing the ROS levels in pDCs in a neutrophil cytosolic factor 1-dependent manner. Taurine supplementation promoted expression of type I IFN-induced genes, activated lymphocytes, and increased autoantibodies and proteinuria, leading to more serious nephritis. CONCLUSION: Taurine metabolism is involved in the development of SLE by enhancing pDC-mediated type I IFN production. Targeted inhibition of taurine or implementation of a taurine-restricted diet has therapeutic potential in SLE.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Li J, Ding H, Meng Y, et al. Taurine Metabolism Aggravates the Progression of Lupus by Promoting the Function of Plasmacytoid Dendritic Cells. Arthritis Rheumatol. 2020. PMID: 32608557. doi:10.1002/art.41419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。